SimBioSys Email Format
Biotechnology ResearchIllinois, United States11-50 Employees
SimBioSys is a biotechnology research company based in Chicago, Illinois, that operates at the intersection of artificial intelligence and biophysical modeling to advance precision oncology. The firm analyzes spatial biophysics within tumors to provide clinicians and researchers with a more comprehensive view of cancer biology, supporting better assessment of treatment options and more individualized patient care. Its team is described as small to mid-sized, reflecting a specialized research focus. Its primary customers are clinicians and researchers in oncology, including breast cancer specialists and academic medical centers, who use its insights to inform decision-making. In the biotech and life sciences landscape, SimBioSys positions itself as a TechBio company applying AI-driven spatial biophysics to cancer care. A notable development in 2024 was a collaboration with Mayo Clinic to develop early-stage breast cancer decision-support tools based on a dynamic contrast-enhanced MRI–based AI platform.